scPharmaceuticals Inc. (SCPH) Misses Q2 EPS by 5c

scPharmaceuticals Inc. (NASDAQ: SCPH) reported Q2 EPS of ($0.34), $0.05 worse than the analyst estimate of ($0.29). Revenue for the quarter came in at $16 million versus the consensus estimate of $15.41 million.

For earnings history and earnings-related data on scPharmaceuticals Inc. (SCPH) click here.

You May Also Be Interested In

• Oracle (ORCL) Reiterated at Market Outperform by Citizens on Positive Due Diligence Results
• Loop Capital Starts Dave Inc (DAVE) at Buy
• Morgan Stanley Downgrades Vend Marketplaces (VEND:NO) to Equalweight